Entia Biosciences, Inc. (ERGO)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 2, 2025
Entia Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
|---|---|---|---|---|---|---|
Period Ending | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
| Cash & Equivalents | 0.08 | 0.02 | 0.1 | 0.04 | 0.01 | Upgrade
|
| Cash & Short-Term Investments | 0.08 | 0.02 | 0.1 | 0.04 | 0.01 | Upgrade
|
| Cash Growth | 215.13% | -75.74% | 169.65% | 181.98% | -21.38% | Upgrade
|
| Accounts Receivable | 0.01 | 0.01 | 0.24 | 0.01 | 0.06 | Upgrade
|
| Other Receivables | - | - | - | 0 | 0 | Upgrade
|
| Receivables | 0.01 | 0.01 | 0.24 | 0.02 | 0.07 | Upgrade
|
| Inventory | 0.07 | 0.04 | 0.05 | 0.14 | 0.13 | Upgrade
|
| Prepaid Expenses | 0.08 | 0.06 | 0.05 | 0.03 | 0.03 | Upgrade
|
| Total Current Assets | 0.23 | 0.13 | 0.44 | 0.23 | 0.24 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.03 | 0.04 | 0.06 | 0.04 | Upgrade
|
| Other Intangible Assets | 0.19 | 0.23 | 0.34 | 0.34 | 0.18 | Upgrade
|
| Other Long-Term Assets | - | 0.06 | 0.05 | - | - | Upgrade
|
| Total Assets | 0.44 | 0.45 | 0.87 | 0.63 | 0.46 | Upgrade
|
| Accounts Payable | 0.65 | 0.6 | 0.38 | 0.61 | 0.43 | Upgrade
|
| Accrued Expenses | 0.71 | 0.37 | 0.17 | 0.54 | 0.22 | Upgrade
|
| Short-Term Debt | 0.73 | 0.28 | 0.43 | 0.42 | 0.14 | Upgrade
|
| Current Portion of Long-Term Debt | 0.01 | - | - | - | 0.32 | Upgrade
|
| Current Portion of Leases | - | - | - | 0 | 0 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.01 | 0.01 | Upgrade
|
| Total Current Liabilities | 2.11 | 1.24 | 0.99 | 1.58 | 1.11 | Upgrade
|
| Long-Term Debt | 0.3 | - | - | - | - | Upgrade
|
| Long-Term Leases | - | - | - | - | 0 | Upgrade
|
| Total Liabilities | 2.41 | 1.24 | 0.99 | 1.58 | 1.11 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 12.49 | 12.31 | 10.77 | 7.79 | 5.12 | Upgrade
|
| Retained Earnings | -14.47 | -13.08 | -10.82 | -8.52 | -5.33 | Upgrade
|
| Comprehensive Income & Other | -0.01 | -0.05 | -0.09 | -0.23 | -0.44 | Upgrade
|
| Total Common Equity | -1.97 | -0.79 | -0.12 | -0.95 | -0.65 | Upgrade
|
| Shareholders' Equity | -1.97 | -0.79 | -0.12 | -0.95 | -0.65 | Upgrade
|
| Total Liabilities & Equity | 0.44 | 0.45 | 0.87 | 0.63 | 0.46 | Upgrade
|
| Total Debt | 1.05 | 0.28 | 0.43 | 0.42 | 0.46 | Upgrade
|
| Net Cash (Debt) | -0.97 | -0.26 | -0.33 | -0.39 | -0.44 | Upgrade
|
| Net Cash Per Share | -0.03 | -0.01 | -0.04 | -0.05 | -0.06 | Upgrade
|
| Filing Date Shares Outstanding | 33.66 | 28.11 | 15.51 | 8.3 | 7.44 | Upgrade
|
| Total Common Shares Outstanding | 28.15 | 28.11 | 15.51 | 8.3 | 7.44 | Upgrade
|
| Working Capital | -1.87 | -1.11 | -0.55 | -1.36 | -0.86 | Upgrade
|
| Book Value Per Share | -0.07 | -0.03 | -0.01 | -0.11 | -0.09 | Upgrade
|
| Tangible Book Value | -2.15 | -1.02 | -0.46 | -1.29 | -0.83 | Upgrade
|
| Tangible Book Value Per Share | -0.08 | -0.04 | -0.03 | -0.16 | -0.11 | Upgrade
|
| Machinery | 0.12 | 0.12 | 0.11 | 0.11 | 0.06 | Upgrade
|
| Leasehold Improvements | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.